An observational study in Dental Implant Failed, Peri-Implantitis and Bone Loss, sponsored by University of Turin, Italy. Status unknown at 1 site in Italy. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-07-30.
Sponsored by University of Turin, Italy · Observational
The aim of this study will be to compare the long-term outcomes of sandblasted and acid-etched (SLA) implants in patients previously treated for periodontitis and in periodontally healthy patients (PHP) after a follow-up of at least 20-years.
304 studies on the registry are indexed under Peri-Implantitis; 84 are open to participants now.
This study's planned enrollment of 149 is above the median of 80 across 116 observational studies indexed under Peri-Implantitis.
Browse Peri-Implantitis studies →University of Turin, Italy is the lead sponsor of 206 studies on the registry; 34 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients attending the principle investigator (M.R.), a specialist in periodontology, for dental implant therapy between December 1998 and September 2001 were screened for possible inclusion in the study.
Exclusion Criteria:
Other: Oral Rehabilitation with dental implants
Other: Oral Rehabilitation with dental implants
Other: Oral Rehabilitation with dental implants
Patients have been treated with oral dental implants supporting fixed dental prostheses
Implant survival rate
Change in percentage of dental implants in situ / dental implants placed
Time frame: Baseline; 10-year at the 20-year follow-up examination
Marginal Bone loss
Changes in mm of the peri-implant marginal bone loss
Time frame: Baseline; 10-year at the 20-year follow-up examination
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Turin, Italy